Does PHENPROCOUMON Cause Basal cell carcinoma? 34 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Basal cell carcinoma have been filed in association with PHENPROCOUMON. This represents 2.5% of all adverse event reports for PHENPROCOUMON.
34
Reports of Basal cell carcinoma with PHENPROCOUMON
2.5%
of all PHENPROCOUMON reports
0
Deaths
34
Hospitalizations
How Dangerous Is Basal cell carcinoma From PHENPROCOUMON?
Of the 34 reports, 34 (100.0%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PHENPROCOUMON. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does PHENPROCOUMON Cause?
Anaemia (242)
General physical health deterioration (172)
Haematochezia (162)
Dyspnoea (140)
Gastrointestinal haemorrhage (122)
Overdose (109)
Dizziness (108)
Haematoma (108)
Product prescribing error (104)
Fall (92)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which PHENPROCOUMON Alternatives Have Lower Basal cell carcinoma Risk?
PHENPROCOUMON vs PHENTERMINE
PHENPROCOUMON vs PHENTERMINE\TOPIRAMATE
PHENPROCOUMON vs PHENTOLAMINE
PHENPROCOUMON vs PHENYLEPHRINE
PHENPROCOUMON vs PHENYLEPHRINE\PHENYLEPHRINE